23 October 2025
Baker McKenzie Advises Takeda in Global Strategic Partnership with Innovent Biologics
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Randy Sunberg | Baker McKenzie | Partner | licensing, option and collaboration agreement | New York |
| Devin Muntz | Baker McKenzie | Associate | licensing, option and collaboration agreement | Chicago |
| Anat Polyachenko | Baker McKenzie | Associate | licensing, option and collaboration agreement | New York |
| Julia Rossié | Baker McKenzie | Associate | licensing, option and collaboration agreement | Munich |
| Christina Lee | Baker McKenzie | Partner | share issuance agreement | Hong Kong |
| Brian Wong | Baker McKenzie | Partner | share issuance agreement | Hong Kong |
| Creighton Macy | Baker McKenzie | Partner | HSR/antitrust matters | Washington, DC |
| Daniel Duk-ki Moon | Baker McKenzie | Associate | HSR/antitrust matters | Washington, DC |
Stated terms
- Stated value
- USD 1.20bn (USD 1.2 billion)
- What the figure measures
- Total transaction value
- Client
- TakedaJoint venture party
- Counterparties
- Innovent Biologics (Joint venture party)